Picture Berlin Partner Top News Robotics Network Berlin-Brandenburg 650x100px

Product › Details

FS001 (Ipsen/Foreseen Biotechnololgy)

	Next higher product group	antibody-drug conjugate (ADC)
	Status	2024-07-11 development pp existent
	Organisation	Ipsen S.A. (Euronext: IPN; ADR: IPSEY)
	Group	Ipsen (Group)
	Organisation 2	Foreseen Biotechnology (CN)

Record changed: 2024-07-14

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x200px

More documents for antibody-drug conjugate (ADC)

[1] Callio Therapeutics. (3/3/25). "Press Release: Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept". Seattle, WA & Singapore....
[2] Alentis Therapeutics AG. (11/12/24). "Press Release: Alentis Therapeutics Raises $181.4 Million in an Oversubscribed Series D Financing to Advance the Clinical Development of Anti-Claudin-1 ADCs in Solid Tumors". Basel....
[3] Alentis Therapeutics AG. (9/3/24). "Press Release: Alentis Appoints Jonathan Freve CFO". Basel....
[4] Ipsen S.A.. (7/11/24). "Press Release: Ipsen and Foreseen Biotechnology Announce Exclusive Global Licensing Agreement for Antibody-Drug Conjugate with First-in-Class Potential". Paris....
[5] Adcytherix SAS. (6/11/24). "Press Release: Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates". Marseille....
[6] Ipsen S.A.. (4/2/24). "Press Release: Ipsen and Sutro Biopharma Announce Exclusive Global Licensing Agreement for an ADC Targeting solid tumors". Paris & San Francisco, CA....
[7] Tubulis GmbH. (3/14/24). "Press Release: Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline". Munich....
[8] Mablink Bioscience SAS. (10/18/23). "Press Release: Mablink Bioscience Enters an Agreement to be Acquired by Lilly". Lyon....
[9] Mablink Bioscience SAS. (10/14/22). "Press Release: Mablink Bioscience Announces a €31 Million Series A Funding Round Led by Sofinnova Partners and Mérieux Equity Partners". Lyon....
[10] ADC Therapeutics S.A.. (7/1/22). "Press Release: ADC Therapeutics Appoints Jean-Pierre Bizzari, MD, to Board of Directors". Lausanne....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)